Brugada Syndrome: Difference between revisions

Jump to navigation Jump to search
m
mNo edit summary
Line 26: Line 26:
{| class="wikitable" border="0" cellpadding="0" cellspacing="0" width="800px"
{| class="wikitable" border="0" cellpadding="0" cellspacing="0" width="800px"
|-
|-
!colspan="1"|'''Findings'''
|- align=left
!colspan="2"|'''Findings'''
|- align=left
|- align=left
|'''ECG'''
|'''ECG'''
|'''OMIM'''
|'Type 1 ECG with coved type ST-elevation'
|'''Gene'''
|'''Protein'''
|'''Functional role in cardiomyocytes'''
|'''Effect of mutation'''
|-
|-
!colspan="1"|'''And at least one of the following'''
!colspan="2"|'''And at least one of the following'''
|-
|- align=left
!colspan="1"|'''And at least one of the following'''
|'''Clinical history'''
|colspan="6" bgcolor="#FFFFCC"|'''OMIM:''' ''Online Mendelian Inheritance in Man'' compendium of human genes and genetic phenotypes; '''BrS1–BrS7:''' Brugada syndrome types 1–7; '''NC:''' no consensus; '''I<sub>Ca,L</sub>:''' L-type calcium current; '''I<sub>f</sub>:''' hyperpolarization-activated current; '''I<sub>K,ATP</sub>:''' ATP-sensitive potassium current; '''I<sub>Na</sub>:''' fast sodium current; '''I<sub>to</sub>:''' transient outward potassium current.
|- Documented ventricular fibrillation
|}
|}


Navigation menu